Workflow
AstraZeneca(AZN) - 2025 Q2 - Earnings Call Transcript
阿斯利康阿斯利康(US:AZN)2025-07-29 22:02

AstraZeneca (AZN) Q2 2025 Earnings Call July 29, 2025 09:00 AM ET Company ParticipantsAndy Barnett - Head of Investor RelationPascal Soriot - CEO & Executive DirectorAradhana Sarin - Group CFO & Executive DirectorDavid Fredrickson - EVP - Oncology BusinessSusan Galbraith - EVP - Oncology R&DRuud Dobber - EVP - BioPharmaceuticals Business UnitSharon Barr - EVP & Biopharmaceuticals R&DMarc Dunoyer - CEO of Alexion & Chief Strategy OfficerJames Gordon - VP - European Pharma Equity ResearchSarita Kapila - Co-He ...